Newland Pharmaceutical Co Ltd
SZSE:301277
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Newland Pharmaceutical Co Ltd
SZSE:301277
|
CN |
|
China Xlx Fertiliser Ltd
HKEX:1866
|
CN |
|
China Tungsten and Hightech Materials Co Ltd
SZSE:000657
|
CN |
Newland Pharmaceutical Co Ltd
Newland Pharmaceutical Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Xuchang, Henan and currently employs 800 full-time employees. The company went IPO on 2022-11-16. Newland Pharmaceutical Co Ltd, formerly Henan Newland Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical research and development. The firm's main business is the research and development, production and sales of pharmaceutical intermediates. The firm's main products are L-p-hydroxyphenylglycine series products and p-toluenesulfonic acid, including D-acid, methyl ester and hydroxydeng salt. The firm also produces pharmaceutical resolution agents. The firm mainly operates its businesses in the domestic and overseas markets.
Newland Pharmaceutical Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Xuchang, Henan and currently employs 800 full-time employees. The company went IPO on 2022-11-16. Newland Pharmaceutical Co Ltd, formerly Henan Newland Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical research and development. The firm's main business is the research and development, production and sales of pharmaceutical intermediates. The firm's main products are L-p-hydroxyphenylglycine series products and p-toluenesulfonic acid, including D-acid, methyl ester and hydroxydeng salt. The firm also produces pharmaceutical resolution agents. The firm mainly operates its businesses in the domestic and overseas markets.
